Germitec, a Bordeaux, France-based MedTech company developing UV-C high-level disinfection solutions, raised $30M in funding.
The round was led by Eurazeo through its Nov Santé Actions Non Cotées fund. Existing shareholders also participated.
The company intends to use the funds to expand its U.S. operations, accelerate its commercial adoption, and invest in research and development to expand its product portfolio.
Led by CEO Vincent Gardès, Germitec is a MedTech company dedicated to designing and manufacturing advanced UV-C disinfection solutions for healthcare environments. Its flagship product line offers healthcare facilities fast, effective, and chemical-free solutions to prevent Healthcare-Associated Infections and improve the standard of care. With global demand for infection prevention on the rise, its solutions are positioned to address critical needs everywhere ultrasounds are performed: fertility (IVF2), gynecology, cardiology and ENT3 among other specialties.
FinSMEs
12/02/2025